National Asset Management, Inc. Abiomed Inc Transaction History

National Asset Management, Inc.

$3.51 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$242.49 - $301.46 $7,274 - $9,043	30 Added 3.53%	881 $217,000
Q2 2022 Aug 12, 2022	BUY	$224.73 - $338.64 $12,135 - $18,286	54 Added 6.78%	851 $211,000
Q1 2022 May 02, 2022	SELL	$277.25 - $366.29 $581,947 - $768,842	-2,099 Reduced 72.48%	797 $264,000
Q4 2021 Jan 28, 2022	BUY	$300.63 - $371.35 $132,577 - $163,765	441 Added 17.96%	2,896 $1.04 Million
Q3 2021 Nov 16, 2021	BUY	$310.19 - $376.2 $343,690 - $416,829	1,108 Added 82.26%	2,455 $800,000
Q2 2021 Aug 10, 2021	BUY	$262.71 - $351.17 $73,821 - $98,678	281 Added 26.36%	1,347 $421,000
Q1 2021 May 13, 2021	SELL	$285.92 - $355.13 $276,770 - $343,765	-968 Reduced 47.59%	1,066 $340,000
Q4 2020 Feb 04, 2021	BUY	$251.88 - $324.2 $98,988 - $127,410	393 Added 23.95%	2,034 $660,000
Q3 2020 Nov 09, 2020	BUY	$255.22 - $317.0 $418,816 - $520,197	1,641 New	1,641 $455,000
Q4 2019 Feb 10, 2020	SELL	$159.31 - $223.54 $317,504 - $445,515	-1,993 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$175.89 - $279.23 $7,387 - $11,727	42 Added 2.15%	1,993 $355,000
Q2 2019 Aug 05, 2019	BUY	$250.96 - $284.94 $37,142 - $42,171	148 Added 8.21%	1,951 $510,000
Q1 2019 May 08, 2019	BUY	$276.39 - $362.25 $55,278 - $72,450	200 Added 12.48%	1,803 $517,000
Q4 2018 Feb 08, 2019	SELL	$281.08 - $444.25 $73,924 - $116,837	-263 Reduced 14.09%	1,603 $523,000
Q3 2018 Nov 08, 2018	BUY	$354.53 - $449.75 $14,890 - $18,889	42 Added 2.3%	1,866 $840,000
Q2 2018 Oct 05, 2018	SELL	$278.07 - $446.21 $1,390 - $2,231	-5 Reduced 0.27%	1,824 $747,000
Q1 2018 May 15, 2018	BUY	$192.49 - $295.85 $352,064 - $541,109	1,829 New	1,829 $533,000

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.

Account